Overview

Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This will be a prospective study examining the use of 99mTc-Annexin V-128 (AxV-128/Tc) single-photon emission computed tomography (SPECT)/computerized tomography (CT) technology in the imaging and functional assessment of the lung of patients with chronic obstructive pulmonary disease (COPD), healthy volunteer smokers without COPD and healthy volunteer subjects without smoking history. The aim of study is to determine if patients with COPD have an increased AxV-128/Tc signal with SPECT/CT.
Phase:
Phase 2
Details
Lead Sponsor:
Columbia University
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)